Table 2 In-hospital mortality for new-onset atrial fibrillation.

From: A nationwide study on new onset atrial fibrillation risk factors and its association with hospital mortality in sepsis patients

Group

n

Event

Model

RR [95% CI]

PAF (%) [95% CI]

Non-AF

1,403,728

172,580

Crude *

1.50 [1.46, 1.54]

1.42 [0.98, 1.81]

New-onset AF

21,327

4832

Model 1#

1.21 [1.18, 1.24]

0.65[0.2, 1.11]

   

Model 2 ##

1.04 [1.01, 1.06]

0.2[− 0.2, 0.6]

   

Model 3 ###

1.03 [1.01, 1.06]

0.2 [− 0.2, 0.6]

  1. *Crude; #Model 1 further adjusted by age and sex, and comorbidities: hypertension, congestive heart failure, myocardial infarction, coronary artery disease, pericarditis, myocarditis, valvular disease, ischemic stroke, other cerebrovascular disease, pulmonary embolism, chronic obstructive pulmonary disease, obstructive sleep apnea, diabetes mellitus, renal disease, cancer; ##Model 2 further adjusted by organ dysfunctions: hepatic, metabolic, hematology, CNS, cardiovascular(except septic shock), septic shock and operations: ventilation, renal replacement therapy; ###Model 3 further adjusted by infection sites: cardiovascular, lower respiratory tract, abdominal, central nervous system, soft tissue or musculoskeletal, blood stream, and genitourinary.
  2. RR: risk ratio, AF: atrial fibrillation, PAF: population attribution fraction.